Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Farmakis

Showing results (191-200 of 297) with videos related to

Pageof 30
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 25, 2016
Immunosenescence in patients with chronic systolic heart failureSotirios Xydonas, John Parissis, Louiza Lioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2016
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcomeDimitrios Farmakis, Panagiotis Simitsis, Vasiliki Bistola, et al.
European Journal of Heart Failure|January 29, 2016
Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcomeJohn Parissis, Dimitrios Farmakis, Nikolaos Kadoglou, et al.
European Urology|July 13, 2004
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II studyDimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, et al.
Heart (British Cardiac Society)|November 11, 2010
Staccato reperfusion improves myocardial microcirculatory function and long-term left ventricular remodelling: a randomised contrast echocardiography studyIgnatios Ikonomidis, Efstathios K Iliodromitis, Stavros Tzortzis, et al.
Atherosclerosis|June 15, 2007
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failureJohn T Parissis, Apostolos Karavidas, Vassiliki Bistola, et al.
The American Journal of Cardiology|December 15, 2010
Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fractionJohn T Parissis, Ignatios Ikonomidis, Pinelopi Rafouli-Stergiou, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 23, 2017
Chitinase-3-like protein-1 (YKL-40) before and after therapy in supraventricular arrhythmiasNikolaos Michelakakis, Georgios J Neroutsos, Anastasia S Perpinia, et al.
American Heart Journal|October 8, 2013
Functional electrical stimulation of peripheral muscles improves endothelial function and clinical and emotional status in heart failure patients with preserved left ventricular ejection fractionApostolos Karavidas, Metaxia Driva, John T Parissis, et al.
European Journal of Heart Failure|October 1, 2009
Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up studyJohn T Parissis, Dimitrios Farmakis, Maria Nikolaou, et al.
Pageof 30

Showing results (191-200 of 297) with videos related to

Sort By:
Pageof 30
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 25, 2016
Immunosenescence in patients with chronic systolic heart failureSotirios Xydonas, John Parissis, Louiza Lioni, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2016
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcomeDimitrios Farmakis, Panagiotis Simitsis, Vasiliki Bistola, et al.
European Journal of Heart Failure|January 29, 2016
Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcomeJohn Parissis, Dimitrios Farmakis, Nikolaos Kadoglou, et al.
European Urology|July 13, 2004
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II studyDimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, et al.
Heart (British Cardiac Society)|November 11, 2010
Staccato reperfusion improves myocardial microcirculatory function and long-term left ventricular remodelling: a randomised contrast echocardiography studyIgnatios Ikonomidis, Efstathios K Iliodromitis, Stavros Tzortzis, et al.
Atherosclerosis|June 15, 2007
Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failureJohn T Parissis, Apostolos Karavidas, Vassiliki Bistola, et al.
The American Journal of Cardiology|December 15, 2010
Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fractionJohn T Parissis, Ignatios Ikonomidis, Pinelopi Rafouli-Stergiou, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 23, 2017
Chitinase-3-like protein-1 (YKL-40) before and after therapy in supraventricular arrhythmiasNikolaos Michelakakis, Georgios J Neroutsos, Anastasia S Perpinia, et al.
American Heart Journal|October 8, 2013
Functional electrical stimulation of peripheral muscles improves endothelial function and clinical and emotional status in heart failure patients with preserved left ventricular ejection fractionApostolos Karavidas, Metaxia Driva, John T Parissis, et al.
European Journal of Heart Failure|October 1, 2009
Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up studyJohn T Parissis, Dimitrios Farmakis, Maria Nikolaou, et al.
Pageof 30